Glenhill Advisors’s AbbVie ABBV Stock Holding History

Glenhill Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-4,312	Closed	-$243K	–	53
2014 Q2	$243K	Sell	4,312 -3,578	-45%	-$188K	0.02%	82
2014 Q1	$406K	Buy	7,890 +3,277	+71%	+$166K	0.04%	88
2013 Q4	$243K	Sell	4,613 -54,972	-92%	-$2.7M	0.02%	85
2013 Q3	$2.67M	Buy	+59,585	New	+$2.64M	0.26%	91

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Glenhill Advisors's ABBV Position: Q3 2014 in Review

Glenhill Advisors sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 4,312 shares — an estimated $243K sold.

Glenhill Advisors first reported a position in ABBV in Q3 2013 and held it in 4 quarters. The position peaked at $2.67M in Q3 2013. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

Glenhill Advisors reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
Glenhill Advisors sold 4,312 AbbVie shares in Q3 2014, an estimated $243K.
Glenhill Advisors first reported a position in AbbVie in Q3 2013 and held it in 4 quarters.
Glenhill Advisors's AbbVie position peaked at $2.67M in Q3 2013.
1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Glenhill Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.